CAR-T Therapy Market Competitive Landscape and Regional Forecast Analysis 2023

Global CAR-T Therapy Market, Industry Trends, Revenue Growth, and Leading Players 2020-2023 CAR-T Therapy Global Market Report 2020 www.tbrc.info Email: info@tbrc.info

Š The Business Research Company. All rights reserved.

• The CAR-T therapy market consists of sales of CAR-T therapy products and related services involved in providing CAR-T therapy to the cancer patients. The CAR-T therapy is an immunotherapy used to treat cancer by using patient’s own cells.

• The global CAR-T therapy market was worth $611.31 million in 2019. It is expected to grow at a compound annual growth rate (CAGR) of 51.10% and reach $3,186.23 million by 2023.

• The regions covered are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

CAR-T Therapy Global Market Report 2020 2

© The Business Research Company. All rights reserved.

Chapters from Table of Content Chapter 1. Executive Summary Chapter 2. CAR-T Therapy Market Characteristics Chapter 3. CAR-T Therapy Market Size And Growth Chapter 4. CAR-T Therapy Market Segmentation Chapter 5. CAR-T Therapy Market Regional And Country Analysis …….

Chapter 26. Key Mergers And Acquisitions In The CAR-T therapy Market Chapter 27. CAR-T therapy Market Trends And Strategies Chapter 28. CAR-T therapy Market Future Outlook and Potential Analysis Chapter 29. Appendix

3

Companies Mentioned: Novartis AG, Kite Pharma, Pfizer Inc, Juno Therapeutics, Celgene Corporation, CARsgen Therapeutics, Sorrento Therapeutics and Legend Biotech.

Segments: • By Type • By Geography

CAR-T Therapy Global Market Report 2020 4

© The Business Research Company. All rights reserved.

Few Points from List of Tables Table 1: Global Historic Market Growth, 2015-2019, $ Billion Table 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion Table 3: Global CAR-T therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion ………..

Table 28: Pfizer Inc Financial Performance Table 29: Juno Therapeutics Financial Performance Table 30: Celgene Corporation Financial Performance

5

Europe

Asia

Americas

The Business Research Company 47 Anchorage Point, 42 Cuba Street, Canary Wharf, London, England, E14 8NE. +44 207 1930 708 Email: info@tbrc.info www.tbrc.info

The Business Research Company, Horizon Avenue, 8-2-603/b/s/1/2 Road Number 10 Banjara Hills Hyderabad (India) 500033 ++91 8897263534 Email: info@tbrc.info www.tbrc.info

The Business Research Company 625 South Avenue, Apt B204, Secane, Philadelphia, PA 19018, USA +1 3156230293 Email: info@tbrc.info www.tbrc.info

Follow us on our social media and message us!

6

Š The Business Research Company. All rights reserved.